List of FDA-Approved Peptides

In the past decades, a growing number of peptides have received approval from the U.S. Food and Drug Administration (FDA). This solidifies their status as an essential class of regulated, rigorously evaluated therapeutics.

But what exactly is an “FDA-approved peptide?” How does it differ from peptides labeled for research use only? This article will break down the science behind these questions. It will also help you understand the current regulatory landscape. Plus, it will give you samples of well-recognized peptide drugs.

What Does “FDA-Approved Peptide” Actually Mean?

Let’s start by grounding this topic in something straightforward slot777 : the FDA does not “approve peptides” in a vacuum. It approves specific peptide-based drugs. These are fully formulated, tested, and regulated products. Plus, they also come with defined indications, manufacturing standards, and safety data.

A peptide only enters the “FDA-approved” category when it passes through extensive review, including:

• Preclinical testing for safety and mechanism
• Multi-phase clinical trials
• Manufacturing validation
• Labeling and post-market monitoring

This process is far more rigorous than the standard used for research-grade peptides. The latter often lacks validated purity, stability data, and safety information. An FDA-approved peptide is a thoroughly studied therapeutic agent. Additionally, it is designed for very specific clinical contexts.

It is important to recognize that a peptide’s approval applies only to the following:

• Exact molecular configuration
• Delivery system
• Indication evaluated by regulators

Structural similarity to an approved peptide does not imply similarity in function, safety, stability, or regulatory status.

Why Peptide Therapeutics Matter

Peptides are exciting for scientists and researchers. This is because they occupy what many describe as a “sweet spot” in drug design:

• They are large enough to bind receptors with high specificity. This quality is similar to hormones or natural ligands. [1]
• They are small enough to be synthetically accessible and chemically tunable. [2]
• Their structure can be strategically modified to improve half-life or stability. [3]

The result? A class of therapeutics capable of targeting receptors and signaling pathways. These come without the manufacturing complexity of full-scale proteins or antibodies.

Major Classes of FDA-Approved Peptides

FDA-approved peptide drugs span a surprisingly wide range of therapeutic areas. Below is a major breakdown of the major categories.

1. Metabolic and Endocrine Peptides

This category includes GLP-1 receptor agonist peptides that mimic glucagon-like peptide-1 (GLP-1). The latter is a hormone involved in metabolic signaling pathways. Peptides in this class are the most studied due to their molecular engineering.

Common FDA-approved GLP-1 analogs include:

• Exenatide – Derived from a naturally occurring peptide present in reptile venom. It is later modified for therapeutic use.
• Liraglutide – Engineered with a fatty-acid side chain to extend its half-life. This is made possible by utilizing albumin binding. This product is also available in research-grade format.
• Semaglutide – The peptide is extensively modified for a long duration of action and receptor affinity. Researchers use its research-grade version for a better understanding.

2. Gastrointestinal and Motility-Related Peptides

The GI system relies heavily on peptide signaling. Thus, it is no surprise that peptide therapeutics play an important role in this field. [5]

Linaclotide

A synthetic peptide that acts on guanylate cyclase-C receptors in the intestinal epithelium. Its design is inspired by natural bacterial enterotoxins. However, it is substantially modified to create a predictable pharmacological effect.

3. Oncology-Related Peptide Therapeutics

Peptide drugs also have a notable presence in cancer-related applications. Some work through hormonal pathways. Others target proteasomal or signaling processes.

Degarelix

Degarelix is an FDA-approved peptide treatment for patients with advanced prostate cancer. It works by suppressing testosterone levels. This hormone is believed to stimulate prostate cancer growth. [5]

Carfilzomib

Carfilzomib supports cancer-related applications, especially in multiple myeloma. Myeloma cells produce large amounts of abnormal proteins. They also depend heavily on proteasome activity for survival. When Carfilzomib blocks this system, damaged proteins accumulate. They create stress inside the cell, triggering programmed cell death. [6] 

4. Additional Peptide Therapeutics Across Diverse Fields

Peptides are not limited to metabolic, GI, or oncologic use. Numerous approved peptides are found in smaller or more specialized categories. These could include:

• Bone and mineral regulation peptides [7]
• Peptides involved in rare hormonal disorders [8]
• Immunomodulatory peptide-derived drugs
• Diagnostic peptides, including radiolabeled agents for imaging [9]

Why Peptide Drugs Succeed: Scientific Advantages

Peptide therapeutics are notable for their specificity and tunability. Here are some core reasons for this:

High Receptor Selectivity

Peptides naturally evolved to interact with receptors. They do this with remarkable precision. Synthetic peptides leverage such a mechanism. This allows researchers to fine-tune binding affinity and activation.

Customizable Structure

Through chemical modifications, researchers can dramatically improve a peptide’s:

• Stability
• Half-life
• Rate of degradation
• Solubility
• Targeting capabilities

Expanding Synthetic Capabilities

Modern solid-phase peptide synthesis (SPPS) is now available. This efficient and automated method allows the creation of peptides with complex sequences. The technology fuels innovation across nearly every category of peptide therapeutics.

Common Misconceptions About Peptides

Peptides are gaining attention in mainstream discussions. One downside of this is the circulation of several misconceptions about them. Here are some of them:

1. “All peptides are FDA-approved.”

Not even close. Most peptides, especially the synthetic ones, are classified as research chemicals. This means they should only be used within research settings. These peptides are not approved for human consumption.

2. “If two peptides look similar, they produce similar effects.”

Peptides are known for being extremely sensitive to structural changes. Even a single amino acid substitution can significantly modify:

• Receptor binding
• Stability
• Activity
• Safety profile

3. “A peptide is safe since it comes from nature.”

Just because it is natural does not mean it is safe. Nature produces biologically active peptides. These range from hormones to venom components. Regulatory approval is what determines safety within specific clinical contexts.

Peptides Under Research: Non-Approved Molecules and Their Investigational Applications

FDA-approved peptides represent a well-established class of regulated therapeutics. However, there is also another separate category for research-only peptides. These are the ones being explored in laboratories.

Research-only peptides are not FDA-approved for human consumption. Instead, they are examined in controlled research environments. The goal is to understand their mechanisms of action, receptor interactions, and potential future applications.

Conclusion

Peptides fill one of the most intriguing research niches. They are recognized for their unique combination of precision, tunability, and biological relevance. This quality has helped many peptide-based therapeutics earn FDA approval.

By understanding which peptides received the FDA approval nod, readers can better appreciate the scientific design principles and regulatory safeguards that shape modern peptide therapeutics.

References:

1. Wang, L., Wang, N., Zhang, W., Cheng, X., Yan, Z., Shao, G., Wang, X., Wang, R., & Fu, C. (2022). Therapeutic peptides: current applications and future directions. Signal Transduction and Targeted Therapy, 7(1), 48. https://doi.org/10.1038/s41392-022-00904-4
2. Explainer: Peptides vs proteins – what’s the difference? (2020, December 7). Institute for Molecular Bioscience – University of Queensland. https://imb.uq.edu.au/article/2017/11/explainer-peptides-vs-proteins-whats-difference
3. Musaimi, O. A., Lombardi, L., Williams, D. R., & Albericio, F. (2022). Strategies for improving peptide stability and delivery. Pharmaceuticals, 15(10), 1283. https://doi.org/10.3390/ph15101283
4. Parikh, A., & Thevenin, C. (2023, May 1). Physiology, gastrointestinal hormonal control. StatPearls – NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK537284/
5. Pulse. (2008, December 24). FDA approves Ferring Pharmaceuticals’ Degarelix (Generic name) for treatment of advanced prostate cancer. Ferring Singapore. https://ferring.sg/fda-approves-ferring-pharmaceuticals-degarelix-generic-name-for-treatment-of-advanced-prostate-cancer/
6. Herndon, T. M., Deisseroth, A., Kaminskas, E., Kane, R. C., Koti, K. M., Rothmann, M. D., Habtemariam, B., Bullock, J., Bray, J. D., Hawes, J., Palmby, T. R., Jee, J., Adams, W., Mahayni, H., Brown, J., Dorantes, A., Sridhara, R., Farrell, A. T., & Pazdur, R. (2013). U.S. Food and Drug Administration Approval: Carfilzomib for the Treatment of Multiple Myeloma. Clinical Cancer Research, 19(17), 4559–4563. https://doi.org/10.1158/1078-0432.ccr-13-0755
7. Gillman, C. E., & Jayasuriya, A. C. (2021). FDA-approved bone grafts and bone graft substitute devices in bone regeneration. Materials Science and Engineering C, 130, 112466. https://doi.org/10.1016/j.msec.2021.112466
8. Musaimi, O. A. (2024). FDA’s stamp of approval: Unveiling peptide breakthroughs in cardiovascular diseases, ACE, HIV, CNS, and beyond. Journal of Peptide Science, 30(11), e3627. https://doi.org/10.1002/psc.3627
9. Graham, M. M., & Menda, Y. (2011). Radiopeptide imaging and therapy in the United States. Journal of Nuclear Medicine, 52(Supplement 2), 56S-63S. https://doi.org/10.2967/jnumed.110.085746